Sifting through countless of stocks in the Health Care Equipment & Supplies industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about investing in Koninklijke Philips N.V. or Smith & Nephew plc because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision.

Read on to learn how Koninklijke Philips N.V. and Smith & Nephew plc compare based on key financial metrics to determine which better meets your investment needs.

About Koninklijke Philips N.V. and Smith & Nephew plc

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health. Koninklijke Philips N.V. has strategic alliance with WellSpan Health to advanced imaging and diagnostics technology products and platforms. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. The company also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, it provides arthroscopic enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, the company offers advanced wound care products for the treatment and prevention of acute and chronic wounds, leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

Latest Health Care Equipment & Supplies and Koninklijke Philips N.V., Smith & Nephew plc Stock News

As of July 30, 2026, Koninklijke Philips N.V. had a $25.6 billion market capitalization, compared to the Health Care Equipment & Supplies median of $334.8 million. Koninklijke Philips N.V.’s stock is down 2.9% in 2026, up 0.5% in the previous five trading days and down 5.64% in the past year.

Currently, Koninklijke Philips N.V.’s price-earnings ratio is 20.3. Koninklijke Philips N.V.’s trailing 12-month revenue is $20.2 billion with a 6.3% net profit margin. Year-over-year quarterly sales growth most recently was -2.2%. Analysts expect adjusted earnings to reach $1.763 per share for the current fiscal year. Koninklijke Philips N.V. does not currently pay a dividend.

As of July 30, 2026, Smith & Nephew plc had a $13.3 billion market cap, putting it in the 81st percentile of all stocks. Smith & Nephew plc’s stock is down 3.8% in 2026, up 3.2% in the previous five trading days and up 2.31% in the past year.

Currently, Smith & Nephew plc’s price-earnings ratio is 45.2. Smith & Nephew plc’s trailing 12-month revenue is $6.2 billion with a 10.1% net profit margin. Year-over-year quarterly sales growth most recently was 7.4%. There are no analysts providing consensus earnings estimates for the current fiscal year. Smith & Nephew plc currently has a 3.0% dividend yield.

How We Compare Koninklijke Philips N.V. and Smith & Nephew plc Stock Grades

Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, make sense of financial ratios, read income statements and analyze recent stock movements. AAII created A+ Investor, a robust data suite that condenses data research in an actionable and customizable way suitable for investors of all knowledge levels, to help investors streamline and work through such data.

AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A‐F grades for each of five key investing factors: value, growth, momentum, earnings estimate revisions and quality. Here, we’ll take a closer look at Koninklijke Philips N.V. and Smith & Nephew plc’s stock grades to see how they measure up against one another.

Learn more about A+ Investor here!

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

Koninklijke Philips N.V. and Smith & Nephew plc Growth Grades

Company	Ticker	Growth
Koninklijke Philips N.V.	PHG	F
Smith & Nephew plc	SNN	A

The foundation of growth investing is seeking out stocks of companies exhibiting strong, consistent and prolonged growth that is expected to continue into the future.

In order to compute the growth score and assign it a letter grade, the percentile ranks for each of three components‐consistency of annual sales growth, five-year sales growth rankings adjusted for extreme levels, and consistency of positive annual cash from operations‐must be determined. These three rank figures are added together, and the sum is ranked against the entire stock universe to arrive at a company’s Growth Score to create an equal distribution of grades.

The companies in the bottom 20% of the stock universe receive Growth Grades of F, considered to be very weak, while those in the top 20% receive A grades, which are considered very strong.

Koninklijke Philips N.V. has a Growth Score of 8, which is Very Weak. Smith & Nephew plc has a Growth Score of 100, which is Very Strong.

The Growth Grade Winner: Smith & Nephew plc

As you can clearly see from the Growth Grade breakdown above, Smith & Nephew plc has a more attractive growth grade than Koninklijke Philips N.V.. For investors who focus solely on how a company is growing relative to other companies in the same industry, Smith & Nephew plc could be a good stock to add to their portfolio. However, it’s important for investors to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

Koninklijke Philips N.V. and Smith & Nephew plc’s Momentum Grades

Company	Ticker	Momentum
Koninklijke Philips N.V.	PHG	D
Smith & Nephew plc	SNN	C

Momentum grades help to uncover stocks experiencing anomalously high rates of return; research finds that stocks with high relative levels of momentum tend to outperform, whereas those with low levels of momentum tend to continue underperforming. Momentum is based on the price change of a stock over a specified period relative to all other stocks.

Typically, AAII looks at the weighted relative strength over the trailing four quarters. The weighted four-quarter relative strength rank is the relative price change for each of the past four quarters. The most recent quarterly price change is given a weight of 40% and each of the three previous quarters are given a weighting of 20%.

Koninklijke Philips N.V. has a Momentum Score of 39, which is Weak. Smith & Nephew plc has a Momentum Score of 45, which is Average.

The Momentum Stock Winner: No Clear Winner

Neither Koninklijke Philips N.V. or Smith & Nephew plc has a strong enough Momentum Grade to be considered a “winner.” Investors considering these companies should do additional due diligence and research to see if either could be a good addition to their portfolios. It’s important to look at a wide range of financial metrics in order to determine if Koninklijke Philips N.V. or Smith & Nephew plc is the better investment when it comes to momentum.

Koninklijke Philips N.V. and Smith & Nephew plc’s Estimate Revisions Grades

Company	Ticker	Earnings Estimate
Koninklijke Philips N.V.	PHG	D
Smith & Nephew plc	SNN	na

Earnings estimate revisions scores consider the magnitude of a company’s earnings surprise in its last two reported fiscal quarters. Often, positive surprises beget further positive surprises‐or at least continued sales growth (the exact opposite is generally true, too).

Estimate revisions offer an indication of what analysts are thinking about the short-term prospects of a firm. Estimate revisions are based on the statistical significance of a firm’s last two quarterly earnings surprises and the percentage change in its consensus estimate for the current fiscal year over the past month and past three months.

Koninklijke Philips N.V. has a Earnings Estimate Score of 21, which is Negative. Smith & Nephew plc does not have a meaningful Earnings Estimate Score.

The Earnings Estimate Revisions Stock Winner: No Clear Winner

Neither Koninklijke Philips N.V. or Smith & Nephew plc has an Earnings Estimate Revisions Grade that could be considered a “winner.” Investors considering these companies should do additional due diligence and research to see if either could be a good addition to their portfolios. It’s important to look at a wide range of financial metrics in order to determine if Koninklijke Philips N.V. or Smith & Nephew plc is the better investment when it comes to estimate revisions.

Other Koninklijke Philips N.V. and Smith & Nephew plc Grades

In addition to Momentum, Estimate Revisions and Growth, A+ Investor also provides grades for Value and Quality.

Successful stock investing involves buying low and selling high, so stock valuation is an important consideration for stock selection. Buying stocks that are going to go up typically means buying stocks that are undervalued in the first place, although momentum investors may argue that point.

AAII’s A+ Investor Quality Grade comes from the ranking of key metrics. Specifically, the quality grade is the percentile rank of the composite of return on assets (ROA), return on invested capital (ROIC), gross profit relative to assets, buyback yield, change in total liabilities to assets, accruals, Z double prime bankruptcy risk (Z) score and F-Score.

These 2 key factors, when combined with the above, provide a holistic view into a particular stock. Further, by joining A+ Investor you can see whether Koninklijke Philips N.V. and Smith & Nephew plc pass any of our 60+ stock screens that have outperformed the market since their creation.

So, Which Is the Better Investment, Koninklijke Philips N.V. or Smith & Nephew plc Stock?

Overall, Koninklijke Philips N.V. stock has a Growth Score of 8, Momentum Score of 39 and Estimate Revisions Score of 21.

Smith & Nephew plc stock has a Growth Score of 100, Momentum Score of 45 and Estimate Revisions Score of .

Comparing Koninklijke Philips N.V. and Smith & Nephew plc’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your portfolio’s asset allocation as well as your risk tolerance and financial goals to see if either of these stocks would make a good fit for you. AAII can help you figure out which investments align with your individual needs and preferences.

Investors are encouraged to do their own due diligence and research. In this way, individuals can effectively become managers of their own assets‐without having to rely on others for financial independence. You can count on AAII for timeless articles on financial planning and stock-picking, unbiased research and actionable analysis.

A+ Investor adds to our qualitative teaching with a powerful data suite to help you whittle down investment choices to find stocks, exchange-traded funds (ETFs) or mutual funds that meet your needs.

AAII Disclaimer

We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown, because past, hypothetical or simulated performance is not necessarily indicative of future results. Before making an investment decision, you should consider your circumstances and whether the information on our content is applicable to your situation. This information was prepared in good faith, and we accept no liability for any errors or omissions. The full disclaimer can be read here.